Coronavirus Update: The Hunt For A Vaccine & Non-COVID-19 Trial Plans Go Awry
Executive Summary
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.
You may also be interested in...
Coronavirus Update: BMS Expands Medicine Program, Cancer Research UK Cuts Funding
Bristol-Myers Squibb is to give away more medicines to uninsured US patients, Cancer Research UK tells of funding hardship, Oxford Biomedica joins a consortium to rapidly develop a vaccine, while a Korean company works on a stem cell therapy.
Industry, Agencies Are Making COVID-19 Partnerships Easy
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.